Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone

Current Drug Delivery

Volumn 10, Issue 4, 2013, Pages 477-491

  Dhakad, Raghvendra Singh ^a   Tekade, Rakesh Kumar ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Dendrimer; Drug targeting; Folate conjugation; Nanoparticle; Receptor up regulation strategy

Indexed keywords

DENDRIMER; DEXAMETHASONE; DOCETAXEL; FOLATE RECEPTOR; FOLIC ACID; NANOCARRIER; RETINOIC ACID;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; PROMOTER REGION; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR UPREGULATION;

EID: 84882749057     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/1567201811310040012     Document Type: Article

References (49)

1. Tekade, R. K.; Vijayarajkumar, P.; Jain, N. K. Dendrimers in oncology: An expanding horizon. Chem. Rev., 2009, 109, 49-87.
2. Tekade, R. K.; Dutta, T.; Gajbhiye, V.; Jain, N. K. Exploring Den-drimer towards Dual Drug Delivery: pH Responsive Simultaneous Drug-Release Kinetics. J. Microencapsul., 2009, 26, 287-296.
3. Kumar, P. V.; Agashe, H.; Dutta, T.; Jain, N. K. PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr. Drug Deliv., 2007, 4, 11-19.
4. Pignatello, R.; Passirani, C. Active targeting strategies for anti cancer drug nanocarriers. Curr. Drug Deliv., 2012, 9, 255-268.
5. Vogel, K.; Wang, S.; Lee, R. J.; Chmielewski, J.; Low, P. S. Peptide mediated release of folate-targeted liposome contents from en-dosomal compartments. J. Am. Chem. Soc., 1996, 118, 1581-1586.
6. Sheth, P.; Sandhu, H.; Singhal, D.; Malick, W.; Shah, N.; Kislalioglu, M. S. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. Curr. Drug Deliv., 2012, 9, 269-284.
7. Dutta, T.; Garg, M.; Jain, N. K. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. Eur. J. Pharm. Sci., 2008, 34, 181-189.
8. Tekade, R. K.; Dutta, T.; Tyagi, A.; Bharti, A. C.; Das, B. C.; Jain, N. K. Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy. J. Drug Target, 2008, 16, 758-772.
9. Kesharwani, P.; Gajbhiye, V., Tekade, R. K.; Jain, N. K. Evaluation of Dendrimer Safety and Efficacy Through Cell Line Studies. Curr. Drug Targets, 2011, 12, 1478-1497.
10. Kesharwani, P.; Tekade, R. K.; Gajbhiye, V.; Jain, K.; Jain N. K. Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison. Nanomed. Nanotechnol. Biol. Med., 2011, 7, 295-304.
11. Ulbrich, V.; Sur, V.; Stohalm, J.; Plocova, D.; Jelinkova, M.; Rihova, B. Polymeric drugs based on conjugates of synthetic and natural macromolecules. Synthesis and physicochemical characterization. J. Control Rel., 2000, 64, 63-79.
12. Lee, P. Y.; Wong, K. K. Y. Nanomedicine: A New Frontier in Cancer Therapeutics. Curr. Drug Del., 2011, 8, 245-253
13. Tomalia, D. A.; Baker, H.; Dewald, J.; Hall, M.; Kallos, G.; Martin, S.; Reck, J.; Ryder, J.; Smith, P. A new class of polymers: star-burst-dendritic macromolecules. Polym. J. 1985, 17, 117-132.
14. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopi matter. Angew. Chem. Int. Ed. Engl. 1990, 29, 138-175.
15. Svenson, S.; Tomalia, D. A. Dendrimers in biomedical applications-reflections on the field. Adv. Drug Deliv. Rev., 2005, 57, 2106-2129.
16. Kulhari, H.; Pooja, D.; Prajapati, S. K.; Chauhan, A. S. Performance evaluation of PAMAM dendrimer based simvastatin formulations. Int. J. Pharm., 2011, 405, 203-209.
17. Dutta, T.; Jain, N. K. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim. Biophys. Acta, 2007, 1770, 681-686.
18. Kannan, S.; Kolhe, P.; Raykova, V.; Glibatec, M.; Kannan, R. M.; Lieh-Lai, M.; Bassett, D. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J. Biomatter. Sci. Polym. Ed. 2004, 15, 311-330.
19. Asthana, A.; Chauhan, A. S.; Diwan, P. V.; Jain, N. K. Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site specific delivery of acidic anti-inflammatory active ingredient. AAPS Pharm. Sci. Tech., 2005, 6, E536-E542.
20. Kolhe, P.; Khandare, J.; Pillai, O.; Kannan, S.; Lai, M. L.; Kannan, R. M. Preparation, cellular transport, and activity of polyami doamine based dendritic nanodevices with a high drug payload. Biomaterials, 2006, 27, 660-669.
21. Tomalia, D. A. Starburst dendrimers - nanoscopic supermolecules according dendritic rules and principles. Macromol. Symp., 1996, 101, 243-255.
22. Patri, A. K.; Majoros, I.; Baker, J. R., Dendritic polymer macromolecular carriers for drug delivery. Curr. Opin. Chem. Biol., 2002, 6, 466-471.
23. Prajapati, R. N.; Tekade, R. K.; Gupta, U.; Gajbhiye, V.; Jain, N. K. Dendimer-Mediated solubilization, formulation development and in vitro-in vivo assessment of Piroxicam. Mol. Pharm., 2009, 6, 940-950.
24. Konda, S. D.; Aref, M.; Wang, S.; Brechbiel, M.; Wiener, E. C. Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Biol. Med., 2001, 12, 104-113.
25. Konda, S. D.; Wang, S.; Brechbiel, M.; Wiener, E. C. Biodistribu-tion of a 153Gd-Folate dendrimer, generation 4, in mice with folate receptor positive and negative ovarian tumor xenografts. Invest. Radiol., 2001, 37, 4199-4204.
26. Quintana, A.; Raczka, E.; Piehler, L.; Lee, I.; Myc, A.; Majoros, I.; Patri, A. K.; Thomas, T.; Mule, J.; Baker, J.R, Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm. Res., 2002, 19, 1310-1316.
27. Thomas, T.P.; Majoros, I. J.; Kotlyar, A.; Kukowska-Latallo, J. F.; Bielinska, A.; Myc, A.; Baker, JR. Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J. Med. Chem., 2005, 48, 3729-3735.
28. Wang, H.; Zheng, X.; Behm, F. G.; Ratnam, M. Differentiation independent retinoid induction of folate receptor type b, a potential tumor target in myeloid leukemia. Blood, 2000, 96, 3529-3536.
29. Pan, X. Q.; Zheng, X.; Shi, G.; Wang, H.; Ratnam, M.; Lee, R. J. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid. Blood, 2002, 100, 594-602.
30. Tran, T.; Shatnawi, A.; Zheng, X.; Kelly, K. M. M.; Ratnam, M. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and argeting. Cancer Res., 2005, 65, 4431-4441.
31. De Brabender-Van, D. B.; Meijer, E. M. Poly (propylene imine) dendrimers: Large-scale synthesis by heterogeneously catalyzed hydrogenation. Angew. Chem. Int. Ed. Engl., 1993, 32, 1665-1688.
32. Bhadra, D.; Bhadra, S.; Jain, N. K. PEGylated peptide-based dendritic nanoparticle systems for delivery of artemther. J. Drug Deliv. Sci. Technol., 2005, 15, 65-73.
33. Kumar, P.V.; Asthana, A.; Dutta, T.; Jain, N. K. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J. Drug Target, 2006, 14, 546-556.
34. Agashe, H. B.; Babbar, A. K.; Jain, S.; Sharma, R. K.; Mishra, A. K.; Asthana, A.; Garg, M.; Dutta, T.; Jain, N.K. Investigation on biodistribution of technetium-99m labeled carbohydrate coated PPI dendrimers. Nanomedicine, 2007, 3, 120-127.
35. Dutta, T.; Garg, M.; Dubey, V.; Mishra, D.; Singh, K.; Pandita, D.; Singh, A. K.; Ravi, A. K.; Velpandian, T.; Jain, N. K. Toxicological Investigation of surface engineered fifth generation poly(propyleneimine) dendrimers in vivo. Nanotoxicology, 2008, 2, 62-70.
36. Dutta, T.; Garg, M.; Jain, N. K. Poly (propyleneimine) dendrimer and dendrosome based genetic immunization against hepatitis B. Vaccine, 2008, 26, 3389-3394.
37. Agarwal, A.; Gupta, U.; Asthana, A.; Jain, N. K. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials, 2009, 30, 3588-3596.
38. Singhai, A. K.; Jain, S.; Jain, N. K. Evaluation of an aqueous injection of Ketoprofen. Pharmazie, 1997, 52, 149-151.
39. Singh, P.; Gupta, U.; Asthana, A.; Jain, N. K. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization and targeted anticancer drug delivery potential in tumor induced mice. Bioconj. Chem., 2008, 19, 2239-2252.
40. Wang, H.; Li, M.; Rinehart, J. J.; Zhang, R. Pretreatment with DEXA Increases Antitumor Activity of Carboplatin and Gemcitabine in Mice Bearing Human Cancer Xenografts: In Vivo Activity, Pharmacokinetics, and Clinical Implications for Cancer Chemotherapy. Clin. Cancer Res., 2004, 10, 1633-1644.
41. Gupta, U.; Dwivedi, S. K. D.; Bid, H. K.; Konwar, R.; Jain, N. K. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells. Int. J. Pharm., 2010, 393, 185-196.
42. Hao, H.; Ratnam, M. Modulation of folate receptor type beta by coordinate actions of retinoic acid receptors at activator Sp1 and repressor AP-1 sites. Blood, 2003, 101, 4551-4560.
43. Schmid, I.; Krall, W. J.; Uittenbogaart, C. H.; Braun, J.; Giorgi, J. V. Dead cell discrimination with 7-amino actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry, 1992, 13, 204-208.
44. Chung, K. N.; Saikawa, Y.; Paik, T. H. Stable transfectants of human MCF-7 breast cancer cells with increased levels of the human folate receptor exhibit an increased sensitivity to antifolates. J. Clin. Invest., 1993, 91, 1289-1294.
45. Thakur, S.; Tekade, R. K.; Kesharwani, P.; Jain N.K. The effect of polyethylene glycol spacer chain length on the tumor targeting potential of folate modified PPI dendrimers. J. Nanopar. Res., 2013, 15, 1-16.
46. Dwivedi, P.; Tekade, R. K.; Jain, N. K. Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer's Disease. Curr. Nanosci., 2013, 9, 46-55.
47. Maheshwari, R. G. S.; Tekade, R. K.; Sharma, P. A.; Gajanan, D.; Tyagi, A.; Patel, R. P.; Jain, D. K. Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: a comparative assessment. Saudi Pharm. J. 2012, 20, 161-170.
48. Gajbhiye, V.; Kumar, P.; Tekade, R. K.; Jain, N. K. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist. Eur. J. Med. Chem., 2009, 44, 1155-1166.
49. Gajbhiye, V.; Kumar, P. V.; Tekade, R. K.; Jain, N. K. Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr. Pharm. Design, 2007, 13, 415-429.